← Dashboard
Stock
DXCM
DEXCOM, INC.Health CareHealth Care EquipmentLatest close $747 of 27 marquee funds currently hold3 CUSIPs mapped
Current holders
7
27 funds tracked
Ever held
14
Current + past
New this quarter
2
Exited this quarter
1
Marquee-fund ownership over time
May 16, 2016Nov 16, 2020Aug 14, 2024May 15, 2026
Now
10
This quarter's activity
New positions opened
Positions exited
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Bridgewater Associates | Q4 2020 | 23Q | $84 | $74 | -13% |
| Renaissance Technologies | Q3 2024(8Q snapshot) | 7Q | $70 | $74 | +5% |
| Citadel Advisors re-entered | Q3 2024(8Q snapshot) | 7Q | $0.00 | $74 | — |
| Soros Fund Management re-entered | Q3 2024(8Q snapshot) | 7Q | $70 | $74 | +5% |
| D.E. Shaw | Q3 2024(8Q snapshot) | 7Q | $70 | $74 | +5% |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $70 | $74 | +5% |
| Point72 Asset Management re-entered | Q1 2025(8Q snapshot) | 5Q | $89 | $74 | -17% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Two Sigma Investments 4× in & out | Q1 2025 | Q2 2026 | — | +0% |
| Millennium Management 3× in & out | Q4 2024 | Q1 2026 | — | +0% |
| Tiger Global | Q1 2024 | Q4 2024 | → $75 | -36% |
| Maverick Capital 3× in & out | Q3 2024 | Q4 2024 | → $75 | +7% |
| Coatue Management 2× in & out | Q3 2020 | Q4 2022 | → $113 | +6% |
| Lone Pine Capital 2× in & out | Q3 2020 | Q1 2022 | → $102 | -4% |
| Viking Global Investors | Q2 2016 | Q3 2016 | → $23 | +45% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at DEXCOM INC. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
Filings · last 30d
23
Filings · last 90d
31
Total on file
662
Recent SEC buffer
Most recent
Jun 5, 2026
30d / 90d windows measured from Jun 5, 2026 — the most recent Form 4 on file — not from today.
- Form 40001093557-26-000127Jun 5, 2026
- Form 40001093557-26-000125Jun 1, 2026
- Form 40001093557-26-000124Jun 1, 2026
- Form 40001093557-26-000123Jun 1, 2026
- Form 40001093557-26-000122Jun 1, 2026
- Form 40001093557-26-000121Jun 1, 2026
- Form 40001093557-26-000120Jun 1, 2026
- Form 40001093557-26-000119Jun 1, 2026
- Form 40001093557-26-000118Jun 1, 2026
- Form 40001093557-26-000117Jun 1, 2026
- Form 40001093557-26-000116Jun 1, 2026
- Form 40001093557-26-000099May 27, 2026
- Form 40001093557-26-000098May 27, 2026
- Form 40001093557-26-000097May 27, 2026
- Form 40001093557-26-000096May 27, 2026
Showing 15 of 662 recent Form 4 filings. Browse all on EDGAR ↗
Fundamentals
XBRL · DEXCOM, INC.Annual figures sourced directly from DEXCOM, INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Revenue
$4.66B
FY2025+16% YoY
Net income
$836.3M
FY2025+45% YoY
EPS (diluted)
$2.09
FY2025+47% YoY
Free cash flow(?)
$1.08B
FY2025+71% YoY
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for DEXCOM INC — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KMaterial eventMay 28, 2026
- 8-KMaterial eventMay 15, 2026
- 10-QQuarterly reportApr 30, 2026
- 8-KMaterial eventApr 30, 2026
- DEF 14AProxy statementApr 15, 2026
- 8-KMaterial eventMar 2, 2026
- 8-KMaterial eventFeb 26, 2026
- 10-KAnnual reportFeb 12, 2026
- 8-KMaterial eventFeb 12, 2026
- 8-KMaterial eventJan 12, 2026
- 8-KMaterial eventDec 22, 2025
- 10-QQuarterly reportOct 30, 2025
- 8-KMaterial eventOct 30, 2025
- 8-KMaterial eventOct 27, 2025
- 8-KMaterial eventSep 16, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q2 2026 | open | $0.00 | — | +0% |
| Soros Fund Management | Q2 2026 | open | $0.00 | — | +0% |
| Citadel Advisors | Q4 2025 | Q1 2026 | $0.00 | — | +0% |
| Point72 Asset Management | Q4 2025 | open | $58 | $65 | +12% |
| Two Sigma Investments | Q1 2025 | Q2 2025 | $0.00 | — | +0% |
| Two Sigma Investments | Q1 2025 | Q2 2026 | $0.00 | — | +0% |
| Point72 Asset Management | Q1 2025 | Q3 2025 | $89 | $80 | -10% |
| Citadel Advisors | Q4 2024 | Q1 2025 | $0.00 | — | +0% |
| Millennium Management | Q4 2024 | Q1 2026 | $0.00 | — | +0% |
| Citadel Advisors | Q3 2024 | Q4 2024 | $0.00 | — | +0% |
| Citadel Advisors | Q3 2024 | open | $70 | $65 | -7% |
| Soros Fund Management | Q3 2024 | Q4 2024 | $70 | $75 | +7% |
| Two Sigma Investments | Q3 2024 | Q4 2024 | $0.00 | — | +0% |
| Two Sigma Investments | Q3 2024 | open | $70 | $65 | -7% |
| D.E. Shaw | Q3 2024 | open | $70 | $65 | -7% |
| AQR Capital Management | Q3 2024 | open | $70 | $65 | -7% |
| Millennium Management | Q3 2024 | Q2 2025 | $0.00 | — | +0% |
| Millennium Management | Q3 2024 | open | $70 | $65 | -7% |
| Maverick Capital | Q3 2024 | Q4 2024 | $70 | $75 | +7% |
| Renaissance Technologies | Q3 2024 | open | $70 | $65 | -7% |
| Tiger Global | Q1 2024 | Q4 2024 | $117 | $75 | -36% |
| Maverick Capital | Q4 2023 | Q2 2024 | $101 | $130 | +28% |
| Maverick Capital | Q4 2020 | Q4 2021 | $85 | $160 | +89% |
| Bridgewater Associates | Q4 2020 | open | $84 | $74 | -13% |
| Lone Pine Capital | Q3 2020 | Q1 2022 | $106 | $102 | -4% |
| Coatue Management | Q3 2020 | Q4 2022 | $106 | $113 | +6% |
| Lone Pine Capital | Q1 2020 | Q2 2020 | $71 | $104 | +47% |
| Coatue Management | Q4 2019 | Q1 2020 | $51 | $71 | +40% |
| Viking Global Investors | Q2 2016 | Q3 2016 | $16 | $23 | +45% |
Caveats
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.